Clinical Trial Update: A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intravenous human normal immunoglobulin 10% in adults with chronic immune thrombocytopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Intravenous immunoglobulin 10% (intravenous immunoglobulin)

Snippet

Sponsor: Kedrion S.p.A. | Conditions: Chronic Primary Immune Thrombocytopenia (ITP) | Phase 3 | Status: RECRUITING